Table 1.
Results for outcomes: fatigue, pain, anxiety, depression, health distress, self-efficacy, and SF-36 at baseline, pre-intervention, post-intervention, 6- and 12-months follow up. Data are mean (SD)
| Outcomes | Baseline | Pre-Ix | Post-Ix | 6 Months | 12 Months |
|---|---|---|---|---|---|
| Fatigue (0–10) | 6.1 (2.4) | 5.7 (2.4) | 5.1 (2.6)a | 5.2 (2.7) | 5.2 (2.9) |
| Pain (0–10) | 5.1 (2.4) | 4.9 (2.2) | 4.8 (2.7) | 4.9 (2.7) | 4.4 (2.9) |
| Anxiety (0–21) | 7.8 (4.1) | 7.4 (3.9) | 6.9 (3.9) | 6.7 (4.0)a | 6.7 (4.5) |
| Depression (0–21) | 6.1 (3.8) | 6.3 (4.3) | 5.6 (3.9)a | 5.2 (3.8)a | 4.9 (3.9)a |
| Health distress (0–5) | 2.3 (1.1)a | 2.1 (1.1) | 2.0 (1.0) | 1.7 (1.2)a | 1.4 (1.1)a |
| Self-efficacy (0–10) | 5.5 (2.1)a | 5.9 (1.9) | 6.1 (2.1) | 6.1 (2.3) | 5.9 (2.8) |
| SF-36 (0–100) | |||||
| Mental health | 44.1 (10.6) | 44.5 (11.1) | 46.5 (9.5)a | 47.2 (10.6)a | 47.8 (10.9)a |
| Role emotional | 40.5 (13.4) | 41.5 (13.2) | 42.6 (13.4) | 45.3 (13.1)a | 46.5 (11.8)a |
| Social function | 39.6 (12.3)a | 41.5 (12.1) | 42.1 (11.1) | 42.8 (13.1) | 43.3 (11.9) |
| Vitality | 38.8 (10.3)a | 40.9 (10.9) | 41.7 (10.4) | 43.7 (11.5)a | 43.7 (12.2)a |
| General health | 39.3 (10.9) | 40.2 (11.5) | 39.3 (11.3) | 41.0 (11.6) | 41.5 (11.5) |
| Bodily pain | 37.3 (7.2)a | 38.9 (7.6) | 38.8 (7.5) | 39.8 (9.0) | 40.6 (9.4) |
| Role physical | 32.7 (10.2)a | 35.0 (11.0) | 36.2 (12.1) | 39.3 (13.0)a | 40.2 (12.1)a |
| Physical function | 34.6 (11.0) | 34.8 (11.5) | 35.6 (11.3) | 37.3 (11.4)a | 38.6 (10.7)a |
asignificantly different to pre-intervention (p < 0.05). Repeated measures ANOVA
Decreasing scores in fatigue, pain, anxiety, depression and health distress signify improvement, while increasing scores in self-efficacy and SF-36 signify improvement
Ix Intervention